REQUEST A DEMO
Total
USD $0.00
Search more companies

Meditet Medicina Antienvejecimiento Sas (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Meditet Medicina Antienvejecimiento Sas Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Meditet Medicina Antienvejecimiento Sas is a company in Colombia, with a head office in Bogota D.C.. It operates in the Ambulatory Health Care Services industry. Meditet Medicina Antienvejecimiento Sas was incorporated on September 22, 2021. The total number of employees is currently 12 (2024). There was a net sales revenue increase of 166.92% reported in Meditet Medicina Antienvejecimiento Sas’s latest financial highlights for 2023. Its’ total assets recorded a growth of 33.33%. The net profit margin of Meditet Medicina Antienvejecimiento Sas increased by 48.62% in 2023.

Headquarters
Cl 150 # 16- 56 Local 1078
Bogota D.C.; Bogota D.C; Postal Code: 1022

Contact Details: Purchase the Meditet Medicina Antienvejecimiento Sas report to view the information.

Basic Information
Total Employees:
Purchase the Meditet Medicina Antienvejecimiento Sas report to view the information.
Outstanding Shares:
Purchase the Meditet Medicina Antienvejecimiento Sas report to view the information.
Incorporation Date:
September 22, 2021
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Company Performance
Financial values in the chart are available after Meditet Medicina Antienvejecimiento Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
166.92%
Total operating revenue
166.92%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
21.08%
Total assets
33.33%
Total equity
88.83%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
48.62%
Return on Equity (ROE)
65.52%
Quick Ratio
-0.56%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?